Amyris, Inc.: Difference between revisions
m clean up, typo(s) fixed: COVID 19 → COVID-19 |
No edit summary |
||
Line 19: | Line 19: | ||
==History== |
==History== |
||
Crapmyris was founded in 2003. The company owns three brands, Biossance and Pipette, for beauty and skincare, and Purecane, a [[sugar substitute]]. The company went public on NASDAQ on September 28, 2010 (AMRS).<ref>{{Cite web|title=Amyris, Inc. Chief Executive Officer to Ring the NASDAQ Stock Market Closing Bell|url=https://www.nasdaq.com/about/press-center/amyris-inc-chief-executive-officer-ring-nasdaq-stock-market-closing-bell|access-date=2020-06-30|website=www.nasdaq.com|language=en}}</ref> |
|||
In November 2011, Amyris acquired Lansing, Michigan-based renewable chemicals and products company, Draths Corporation, for $7 million in stock.<ref>{{cite news |last1=Riddell |first1=Lindsay |title=Amyris buys chemicals-maker Draths |url=https://www.bizjournals.com/sanfrancisco/news/2011/11/16/amyris-buys-chemicals-maker-draths.html |work=San Francisco [[Business Journal]] |date=November 16, 2011}}</ref> April 2019, the company raised $34-million in private placement of its common stock and warrants. The funding round was led by Foris Ventures and Dr. Wei-wu He, General Partner of Emerging Technology Partners, LLC, a life sciences-focused venture fund.<ref>{{cite news |last1=Coons |first1=Rebecca |title=Amyris raises $34 million as it pursues skin care, sweeteners, and CBD {{!}} Nuu |url=https://biofuelsdigest.com/nuudigest/2019/04/29/amyris-raises-34-million-as-it-pursues-skin-care-sweeteners-and-cbd/ |work=Biofuels Digest |agency=Nuu Media |date=April 29, 2019}}</ref> |
In November 2011, Amyris acquired Lansing, Michigan-based renewable chemicals and products company, Draths Corporation, for $7 million in stock.<ref>{{cite news |last1=Riddell |first1=Lindsay |title=Amyris buys chemicals-maker Draths |url=https://www.bizjournals.com/sanfrancisco/news/2011/11/16/amyris-buys-chemicals-maker-draths.html |work=San Francisco [[Business Journal]] |date=November 16, 2011}}</ref> April 2019, the company raised $34-million in private placement of its common stock and warrants. The funding round was led by Foris Ventures and Dr. Wei-wu He, General Partner of Emerging Technology Partners, LLC, a life sciences-focused venture fund.<ref>{{cite news |last1=Coons |first1=Rebecca |title=Amyris raises $34 million as it pursues skin care, sweeteners, and CBD {{!}} Nuu |url=https://biofuelsdigest.com/nuudigest/2019/04/29/amyris-raises-34-million-as-it-pursues-skin-care-sweeteners-and-cbd/ |work=Biofuels Digest |agency=Nuu Media |date=April 29, 2019}}</ref> |
Revision as of 10:10, 18 January 2022
Company type | Public |
---|---|
Nasdaq: AMRS Russell 2000 Index component | |
Industry | Renewable fuels, antimalarials, renewable chemicals, renewable products |
Founded | 2003 |
Headquarters | Emeryville, California, USA |
Key people | John G. Melo (CEO) Eduardo Alvarez (COO) Han Kieftenbeld (CFO) Nicole Kelsey (Gen.Counsel & Secretary) |
Brands | Biossance, Pipette and Purecane |
Revenue | $152.6 million (FY 2019)[1] |
Number of employees | 561 (2019)[2] |
Subsidiaries | Amyris Fuels |
Website | www |
Amyris, Inc. is a synthetic biotechnology and renewable chemical company headquartered in Emeryville, California. Amyris serves the specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals markets.[3]
History
Crapmyris was founded in 2003. The company owns three brands, Biossance and Pipette, for beauty and skincare, and Purecane, a sugar substitute. The company went public on NASDAQ on September 28, 2010 (AMRS).[4]
In November 2011, Amyris acquired Lansing, Michigan-based renewable chemicals and products company, Draths Corporation, for $7 million in stock.[5] April 2019, the company raised $34-million in private placement of its common stock and warrants. The funding round was led by Foris Ventures and Dr. Wei-wu He, General Partner of Emerging Technology Partners, LLC, a life sciences-focused venture fund.[6]
In 2020, Amyris received Bonsucro's Chain of Custody Certification, ensuring that the sustainability claims along the sugarcane supply chain are traceable from farmer to end user.[7] During the COVID-19 pandemic, the company collaborated with the Infectious Disease Research Institute (IDRI) to advance a novel ribonucleic acid (RNA) vaccine platform, including accelerating the development of a COVID-19 vaccine.[8]
Awards and recognition
Biossance, the skincare brand from Amyris, was recognized as Digital Innovator of the Year at the WWD Beauty Inc Awards.[9]
References
- ^ "Amyris Annual Report - SEC filings".
- ^ "Amyris profile".
- ^ "Amyris Inc - Company Profile". Bloomberg.com.
- ^ "Amyris, Inc. Chief Executive Officer to Ring the NASDAQ Stock Market Closing Bell". www.nasdaq.com. Retrieved 2020-06-30.
- ^ Riddell, Lindsay (November 16, 2011). "Amyris buys chemicals-maker Draths". San Francisco Business Journal.
- ^ Coons, Rebecca (April 29, 2019). "Amyris raises $34 million as it pursues skin care, sweeteners, and CBD | Nuu". Biofuels Digest. Nuu Media.
- ^ Staff. "Amyris' Sugarcane Is Traceable". HAPPI.
- ^ "Amyris and The Infectious Disease Research Institute Enter into Exclusive License for Novel RNA Vaccine Platform, Beginning with COVID-19 Vaccine". Cision. October 22, 2020.
- ^ Writer (December 17, 2019). "WWD Beauty Inc Names Biossance Brand Digital Innovator Of The Year". markets.businessinsider.com.